Compound E 是γ-分泌酶抑制剂。 Compound E 抑制 β-amyloid(40),β-amyloid(42),和Notch γ-分泌酶切割的 IC50 值分别为 0.24,0.37,0.32 nM。γ-分泌酶和Notch加工的一种细胞可渗透的、有效的、选择性的、拟肽的、非过渡态类似物抑制剂(在过表达野生型βAPP的CHO细胞中,Aβ40的IC50为300 pM;在用βAPP695和mNotchΔE(M1727V)稳定转染的HEK293细胞中,Aβ40、Aβ42、NICD的IC50分别为240 pM、370 pM、320 pM;在SPA4CT稳定转染的SH-SY5Y细胞中,Aβ40和Aβ42的IC50为100 pM)在几个APP转基因小鼠模型中降低Aβ水平。据报道,与早老素结合并抑制跨膜蛋白底物的蛋白水解裂解,包括APLP1和APLP2、CD44、ErbB4、E-钙粘蛋白、低密度脂蛋白受体相关蛋白、Notch配体和p75NTR。在更高浓度(200-400 µM)下,对早老酶活性的影响很弱。
Compound E is a γ-secretase inhibitor. Compound E blocks β-amyloid(40), β-amyloid(42), and Notch γ-secretase cleavage with IC50s of 0.24, 0.37, 0.32 nM, respectively.A cell-permeable, potent, selective, peptidomimetic, non-transition-state analog inhibitor of γ-secretase and Notch processing (IC50 = 300 pM for Aβ40 in CHO cells overexpressing wild type βAPP; 240 pM for Aβ40, 370 pM for Aβ42, and 320 pM for NICD, respectively, in HEK293 cells stably transfected with βAPP695 and mNotchΔE(M1727V); 100 pM for both Aβ40 and Aβ42 in SH-SY5Y cells stably transfected with SPA4CT). Lowers Aβ levels in several APP transgenic mouse models. Reported to bind to presenilins and suppress the proteolytic cleavage of transmembrane protein substrates, including APLP1 and APLP2, CD44, ErbB4, E-cadherin, low density lipoprotein receptor-related proteins, Notch ligands, and p75NTR. Only weakly affects presenilinase activity at much higher concentrations (200-400 µM).